The fact
The experiment targets costly treatments like trastuzumab, in partnership with hospitals.
If successful, this model could expand to other critical drugs by 2025.
The experiment targets costly treatments like trastuzumab, in partnership with hospitals.
If successful, this model could expand to other critical drugs by 2025.